Related Experiment Video
Updated: Oct 29, 2025
07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.8K
Immunotherapy for Head and Neck Cancer.
Sumita Trivedi1, Lova Sun1, Charu Aggarwal1
1Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Hematology/Oncology Clinics of North America
|July 10, 2021
Summary
Head and neck squamous cell carcinomas (HNSCC) present a significant global health challenge. Recent advancements focus on novel immune-directed therapies to improve outcomes for recurrent or metastatic HNSCC patients.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Head and neck squamous cell carcinomas (HNSCC) contribute significantly to global cancer morbidity and mortality.
- Historically, treatment outcomes for recurrent or metastatic HNSCC were poor, with limited therapeutic options.
- The demographic landscape of HNSCC is shifting, with rising rates of human papilloma virus-associated oropharyngeal carcinoma and declining tobacco-related cases.
Purpose of the Study:
- To review recent therapeutic developments in Head and Neck Squamous Cell Carcinoma (HNSCC).
- To explore novel, immune-directed strategies for HNSCC treatment.
- To discuss emerging therapeutic approaches for future HNSCC management.
Main Methods:
- Literature review of recent advancements in HNSCC treatment.
- Analysis of immune dysregulation in HNSCC.
- Synthesis of current and emerging therapeutic strategies.
Main Results:
- The treatment paradigm for HNSCC has evolved significantly.
- Novel immune-directed therapies show promise by targeting immune dysregulation.
- Emerging strategies are being developed for more effective HNSCC treatment.
Conclusions:
- Recent breakthroughs offer new hope for HNSCC patients, particularly those with advanced disease.
- Immune-directed therapies represent a rapidly advancing frontier in HNSCC management.
- Future research directions focus on optimizing these novel strategies for improved patient survival and quality of life.
Related Concept Videos
01:27Tumor Immunotherapy
781
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
781
02:49Cancer Therapies
8.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
01:30Cancer Vaccines
586
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
586
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
02:50Combination Therapies and Personalized Medicine
5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
01:27Cytotoxic T Cells-mediated Immune Response
5.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
5.3K